Study on possible mechanism of orotic acid-induced fatty liver in rats

Nutrition

Volumn 27, Issue 5, 2011, Pages 571-575

  Wang, Yu Ming ^a   Hu, Xiao Qian ^a   Xue, Yong ^a   Li, Zhao Jie ^a   Yanagita, Teruyoshi ^b   Xue, Chang Hu ^a  

^a OCEAN UNIVERSITY OF CHINA   (China)

^b SAGA UNIVERSITY   (Japan)

Author keywords

Fatty acid oxidation; Fatty liver; Lipid metabolism; Lipogenesis; Microsomal triacylglycerol transfer protein; Orotic acid; Transcription regulatory factors

Indexed keywords

CARNITINE PALMITOYLTRANSFERASE; CHOLESTEROL; FATTY ACID SYNTHASE; LIVER ENZYME; MESSENGER RNA; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; OROTIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PHOSPHOLIPID; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRANSCRIPTION FACTOR; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; FATTY ACID OXIDATION; FATTY ACID SYNTHESIS; FATTY LIVER; GENE EXPRESSION; GENE TARGETING; LIPID LIVER LEVEL; LIPOPROTEIN SECRETION; MALE; MOLECULAR PATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION;

ANIMALS; CARNITINE O-PALMITOYLTRANSFERASE; CHOLESTEROL; CHOLESTEROL, VLDL; DIET; FATTY ACID SYNTHETASE COMPLEX; FATTY LIVER; LIPID METABOLISM; LIVER; MALE; OROTIC ACID; PHOSPHOLIPIDS; RATS; RATS, WISTAR; RNA, MESSENGER; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRIGLYCERIDES; UP-REGULATION;

RATTUS;

EID: 79953281026     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2010.03.005     Document Type: Article

References (33)

1. Neuschwander-Tetri B.A., Caldwell S.H. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 2003, 37:1202-1219.
2. Powell E.E., Cooksley W.G., Hanson R., Searle J., Halliday J.W., Powell L.W. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 1990, 11:74-80.
3. Ratziu V., Giral P., Charlotte F., Bruckert E., Thibault V., Theodorou I., et al. Liver fibrosis in overweight patients. Gastroenterology 2000, 118:1117-1123.
4. Kotronen A., Yki-Järvinen H. Fatty liver-a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol 2008, 28:27-38.
5. Sanyal A.J. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 2002, 123:1705-1725.
6. Deng Q.G., She H., Cheng J.H., French S.W., Koop D.R., Xiong S., et al. Steatohepatitis induced by intragastric overfeeding in mice. Hepatology 2005, 42:905-914.
7. Lieber C.S., Leo M.A., Mak K.M., Xu Y., Cao Q., Ren C., et al. Model of nonalcoholic steatohepatitis. Am J Clin Nutr 2004, 79:502-509.
8. Anstee Q.M., Goldin R.D. Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. Int J Exp Pathol 2006, 87:1-16.
9. Creasey W.A., Hankin L., Handschumacher R.E. Fatty livers induced by orotic acid. I. Accumulation and metabolism of lipids. J Biol Chem 1961, 236:2064-2070.
10. Fukuwatarti T., Morikawa Y., Sugimoto E., Shibata K. Effects of fatty liver induced by niacin-free diet with orotic acid on the metabolism of tryptophan to niacin in rats. Biosci Biotechnol Biochem 2002, 66:1196-1204.
11. Standerfer S.B., Handler P. Fatty liver induced by Orotic acid feeding. Prec See Exp Biol Med 1955, 90:270-271.
12. Cha J.Y., Mameda Y., Yamamoto K., Oogami K., Yanagita T. Association between hepatic triacylglycerol accumulation induced by administering orotic aid and enhanced phosphatidate phosphohydrolase activity in rats. Biosci Biotechnol Biochem 1998, 62:508-513.
13. De Hoff J.L., Davidson J.H., Kritchevsky D. An enzymatic assay for determining free and total cholesterol in tissues. Clin Chem 1978, 24:433-435.
14. Bartlett G.R. Phosphorous assay in column chromatography. J Biol Chem 1959, 234:466-468.
15. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 1951, 193:265-275.
16. Ikeda I., Cha J.Y., Yanagita T., Nakatani N., Oogami K., Imaizumi K., et al. Effects of dietary alpha-linolenic, eicosapentaenoic and docosahexaenoic acids on hepatic lipogenesis and beta-oxidation in rats. Biosci Biotechnol Biochem 1998, 62:675-680.
17. Wetterau J.R., Aggerbeck L.P., Bouma M.E., Eisenberg C., Munck A., Hermier M., et al. Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia. Science 1992, 258:999-1001.
18. Desvergne B., Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 1999, 20:649-688.
19. Jamil H., Chu C.H., Dickson J.K., Chen Y., Yan M., Biller S.A., et al. Evidence that microsomal triglyceride transfer protein is limiting in the production of apolipoprotein B-containing lipoproteins in hepatic cells. J Lipid Res 1998, 39:1448-1454.
20. White D.A., Bennett A.J., Billett M.A., Salter A.M. The assembly of triacylglycerol-rich lipoproteins: an essential role for the microsomal triglyceride transfer protein. Br J Nutr 1998, 80:219-229.
21. Horton J.D., Goldstein J.L., Brown M.S. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 2002, 109:1125-1131.
22. Lee S.S., Pineau T., Drago J., Lee E.J., Owens J.W., Kroetz D.L., et al. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol Cell Biol 1995, 15:3012-3022.
23. Koteish A., Diehl A. Animal models of steatosis. Semin Liver Dis 2001, 21:89-104.
24. Buang Y., Wang Y.M., Cha J.Y., Nagao K., Yanagita T. Dietary phosphatidylcholine alleviates fatty liver induced by orotic acid. Nutrition 2005, 21:867-873.
25. Osborne T.F. Sterol regulatory element-binding proteins (SREBPs): key regulators of nutritional homeostasis and insulin action. J Biol Chem 2000, 275:32379-32382.
26. Shimano H., Horton J.D., Hammer R.E., Shimomura I., Brown M.S., Goldstein J.L. Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a. J Clin Invest 1996, 98:1575-1584.
27. Rao M.S., Reddy J.K. Peroxisomal beta-oxidation and steatohepatitis. Semin Liver Dis 2001, 21:43-55.
28. Reddy J.K., Hashimoto T. Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system. Annu Rev Nutr 2001, 21:193-230.
29. McGarry J.D., Brown N.F. The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur J Biochem 1997, 244:1-14.
30. Braissant O., Foufelle F., Scotto C., Dauça M., Wahli W. Differential expression of peroxisome proliferator-activated receptors: tissue distribution of PPAR-α, -β and -γ in the adult rat. Endocrinology 1996, 137:354-366.
31. Windmueller H.G., Spaeth A.E. Perfusion in situ with tritium oxide to measure hepatic lipogenesis and lipid secretion. Normal and orotic acid-fed rats. J Biol Chem 1966, 241:2891-2899.
32. Wetterau J.R., Gregg R.E., Harrity T.W., Arbeeny C., Cap M., Connolly F., et al. An MTP inhibitor that normalizes atherogenic lipoprotein levels in WHHL rabbits. Science 1998, 282:751-754.
33. Raabe M., Veniant M.M., Sullivan M.A., Zlot C.H., Bjorkegren J., Nielsen L.B., et al. Analysis of the role of microsomal triglyceride transfer protein in the liver of tissue-specific knockout mice. J Clin Invest 1999, 103:1287-1298.